(Q34017119)

30 July 2017

1 reference

title

Premature cardiovascular disease in chronic renal failure (English)

1 reference

30 July 2017

main subject

cardiovascular disease

1 reference

C Baigent

1 reference

30 July 2017

K Burbury

series ordinal

1 reference

30 July 2017

D Wheeler

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

30 July 2017

1 reference

inferred from page(s)

published in

The Lancet

1 reference

30 July 2017

volume

356

1 reference

30 July 2017

issue

9224

1 reference

30 July 2017

page(s)

147-152

1 reference

Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Serum Creatinine Concentration and Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Dialysis-associated ischemic heart disease: insights from coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Cause of death in patients with end-stage renal disease: death certificates vs registry reports.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Lipid abnormalities in end stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Low-density lipoprotein subfraction profiles in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Lipoproteins and apolipoproteins during the progression of chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Increased serum lipoprotein(a) levels in patients with early renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Lipoprotein(a) in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

The effect of reduced glomerular filtration rate on plasma total homocysteine concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902456-9

7 January 2021

10.1016/S0140-6736(00)02456-9

Identifiers

DOI

1 reference

30 July 2017

1 reference